MedPath

Treating shrinking of the lungs by an antibiotic

Not Applicable
Conditions
Health Condition 1: null- Patients suffering from idiopathic pulmonary disease
Registration Number
CTRI/2011/11/002108
Lead Sponsor
Institute of Pulmocare Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

?Informed written consent being given.

?Male and female patients aged 30 to70 years observing the major and minor criteria according to the ATS-ERS guideline.

?IPF diagnosed from pooled expert opinion on HRCT chest.

?No significant occupational history

?FVC more than 40% of prediced

?Non pregnant, non lactating woman

Exclusion Criteria

?History of exacerbation in past 1 month

?History of Doxy allergy

?Having any obvious contraindication for Doxycycline

?Unable to meet the demand of the protocol for any reason

?Significant abnormality in liver or renal function

?Feature of chronic congestive cardiac failure (supported by echocardiography)

?Known case of IPF with CVD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinicoradiological with spirometric chanes.Timepoint: Two yrs
Secondary Outcome Measures
NameTimeMethod
change in Matrix metalloproteinases concentration in Bronchoalveolar lavage (BAF).Timepoint: Two yrs.
© Copyright 2025. All Rights Reserved by MedPath